Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00100
|
|||||
Drug Name |
Adenosine monophosphate
|
|||||
Synonyms |
(S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(dihydrogen phosphate); 1H-Pyrazolo(4,3-d)pyrimidine, 7-amino-3-beta-D-ribofuranosyl-, 5'-(dihydrogen phosphate)-, hydrate; 5'-AMP; 5'-Adenylic acid, homopolymer; 5'-Deoxy-5'-thioadenosine 5'-monophosphate; 5'-O-phosphonatoadenosine; 5'-O-phosphonoadenosine; 5'-Thio-5'-adenylic acid; 5'-adenosine monophosphate; 5'-adenylic acid; 7-Amino-3-beta-D-ribofuranosyl-1H-pyrazolo(4,3-d)pyrimidine 5'-(dihydrogen phosphate) hydrate; 7A8E6D15-9136-44C1-88C9-E1A224638E56; 7gpb; 8-Aminoadenosine 5'-monophosphate; 8gpb; A-5mp; ADENOSINE-5'-PHOSPHATE; AMP; AMP (VAN); AMP (nucleotide); AMP dianion; ASMP; Adenine polynucleotides; Adenosine 5'-(dihydrogen phosphate); Adenosine 5'-monophosphate; Adenosine 5'-monophosphoric acid; Adenosine 5'-phosphate; Adenosine 5'-phosphoric acid; Adenosine Monophosphate (Amp); Adenosine phosphate; Adenosine phosphate (USAN/INN); Adenosine phosphate [USAN:BAN:INN]; Adenosine phosphate [USAN:INN:BAN]; Adenosine, mono(dihydrogen phosphate) (ester); Adenosine-5'-monophosphate; Adenosine-5'-monophosphoric acid; Adenosine-5'P; Adenosine-5-monophosphate dianion; Adenosine-5-monophosphate(2-); Adenosine-5-monophosphoric acid; Adenosine-5-phosphate; Adenosine-monophosphate; Adenosine-phosphate; Adenosini phosphas; Adenosini phosphas [INN-Latin]; Adenovite; Adenyl; Adenyl (TN);Adenylic acid (VAN); Adenylate; Adenylic acid; Ado5'P; Cardiomone; Ergadenylic acid; Formycin 5'-monophosphate hydrate; Formycin 5'-phosphate; Formycin 5'-phosphate hydrate; Formycin A 5'-monophosphate hydrate; Fosfato de adenosina; Fosfato de adenosina [INN-Spanish]; GAMMA-ARSONO-BETA, GAMMA-METHYLENEADENOSINE-5'-DIPHOSPHATE; Lycedan; Monophosphadenine; Muscle adenylic acid; Muskeladenosin-phosphorsaeure; Muskeladenylsaeure; My-B-Den; Myoston; PAdo; POLY A; Phosaden; Phosphaden; Phosphate d'adenosine; Phosphate d'adenosine [INN-French]; Phosphentaside; Polyadenylic acids; Vitamin B8; [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Dietary shortage [ICD11:5B7Z] | Approved | [1] | |||
Therapeutic Class |
Dietary supplement
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C10H14N5O7P
|
|||||
Canonical SMILES |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)O)O)O)N
|
|||||
InChI |
InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
|
|||||
InChIKey |
UDMBCSSLTHHNCD-KQYNXXCUSA-N
|
|||||
CAS Number |
CAS 61-19-8
|
|||||
Pharmaceutical Properties | Molecular Weight | 347.22 | Topological Polar Surface Area | 186 | ||
Heavy Atom Count | 23 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 11 | |||
XLogP |
-3.5
|
|||||
PubChem CID | ||||||
PubChem SID |
3322
,583720
,583923
,584440
,584442
,584452
,584455
,584487
,584571
,585427
,610407
,819401
,819945
,819947
,819949
,820210
,820387
,820906
,821396
,823646
,823841
,824145
,824148
,826522
,826525
,826568
,826569
,827049
,827589
,827693
,827918
,828361
,828365
,828366
,828368
,828899
,830720
,830875
,832127
,832329
,832477
,832865
,833689
,834616
,836112
,837134
,838177
,838245
,838945
,841545
|
|||||
ChEBI ID |
ChEBI:16027
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | PMP34 | Transporter Info | Peroxisomal membrane protein PMP34 | Substrate | [2] | |
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | PMP34 | Transporter Info | Km =190 microM | Human liver cancer cells (HepG2)-PMP34 | [2] | |
References | ||||||
1 | Bitter blocker backed by FDA | |||||
2 | The human gene SLC25A17 encodes a peroxisomal transporter of coenzyme A, FAD and NAD+. Biochem J. 2012 Apr 1;443(1):241-7. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.